Harrow, Inc. (HROW)
47.06
-4.04
(-7.91%)
USD |
NASDAQ |
Dec 12, 16:00
47.01
-0.05
(-0.11%)
After-Hours: 20:00
Harrow Cash from Investing (Quarterly): -0.225M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -3.812M |
| Skye Bioscience, Inc. | 7.967M |
| Theravance Biopharma, Inc. | -100.25M |
| FibroGen, Inc. | 87.16M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.59M |
| Cash from Financing (Quarterly) | 4.964M |
| Free Cash Flow | -20.62M |
| Free Cash Flow Per Share (Quarterly) | 0.4209 |
| Free Cash Flow to Equity (Quarterly) | -4.258M |
| Free Cash Flow to Firm (Quarterly) | 22.40M |
| Free Cash Flow Yield | -1.17% |